New drug SON-DP enters early human trials for liver and stomach cancers
Disease control
Recruiting now
This early-phase trial is testing a new drug called SON-DP in 96 adults with advanced solid tumors, specifically liver and gastric cancers. The main goals are to check the drug's safety, find the right dose, and see if it can control the disease. Participants receive SON-DP throu…
Phase: PHASE1 • Sponsor: Qurgen Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:10 UTC